Stockreport

BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF Results from RATIONALE-315, 307 and 305 support the benefits of PD-1 inhibitor TEVIMBRA (tislelizumab) in non-small cell lung cancer and gastric cancer/gastroesophageal [Read more]